** Shares of Recce Pharmaceuticals RCE.AX fall 7.7% to A$0.300, their lowest levels since April 2, 2020
** The pharmaceutical co announces a placement of A$5 million ($3.06 million) and an entitlement offer of A$10.8 million to fund clinical trials in Indonesia and Australia
** Issue price of A$0.28 for the placement represents a 13.8% discount to co's last close
** Stock down ~38% YTD, including current session's moves
($1 = 1.6332 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。